Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
journal contribution
posted on 2025-04-15, 00:12 authored by S Tissera, B Billah, M Brand, MN Karim, P Antippa, R Blum, M Caldecott, M Conron, Wasek FaisalWasek Faisal, S Harden, I Olesen, P Parente, G Richardson, E Samuel, K See, C Underhill, G Wright, J Zalcberg, RG StirlingStage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator
History
Journal
Clinical Lung CancerVolume
25Pagination
e466-e478Location
Amsterdam, The NetherlandsPublisher DOI
Open access
- No
ISSN
1525-7304eISSN
1938-0690Language
engPublication classification
C1.1 Refereed article in a scholarly journalIssue
8Publisher
ElsevierPublication URL
Usage metrics
Keywords
AgedAged, 80 and overAustraliaCarcinoma, Non-Small-Cell LungFemaleGuideline AdherenceHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingPractice Guidelines as TopicQuality Indicators, Health CareRegistriesSurvival RateGuideline concordant careLung cancerLung cancer survivalNSCLCRisk modellingStage-specifc treatment
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC